Axe Compute (AGPU) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
15 May, 2026Executive summary
Shifted strategic focus to GPU compute services and digital asset (ATH) treasury management, reducing legacy drug discovery operations and exploring strategic alternatives for the legacy business.
Announced a major $260 million, 36-month enterprise infrastructure contract for AI compute services, with deployment targeted for Q3 2026.
Leadership changes included a new CEO, President, and CFO appointments during and after the quarter.
Financial highlights
Revenue for Q1 2026 was $35,311, down from $110,310 year-over-year, reflecting reduced activity in drug discovery.
Net loss from continuing operations was $7.7 million, compared to $2.3 million in Q1 2025.
Loss on digital assets (ATH) was $4.3 million, driven by fair value changes in ATH holdings.
Cash and cash equivalents at March 31, 2026, were $6.9 million, with $20.2 million in digital assets.
Working capital was $33.4 million at quarter-end.
Outlook and guidance
Management expects continued operating losses in the near term as the company scales GPU compute and treasury initiatives.
Liquidity is considered sufficient for at least the next twelve months, with access to ATM and SEPA equity facilities if needed.
The $260 million contract is expected to drive significant revenue growth starting in the second half of 2026.
Latest events from Axe Compute
- Raised $343.5M, secured $12M in contracts, and ended 2025 with a $233M net loss.AGPU
Q4 202517 May 2026 - Q2 2024 saw a $3.2M loss, cost cuts, and new AI/ML partnerships amid going concern risks.AGPU
Q2 20241 Feb 2026 - Registering 1.98M shares for resale; proceeds from warrant exercises fund operations.AGPU
Registration Filing16 Dec 2025 - AI-driven oncology firm shifts capital to Aethir tokens, heightening volatility and regulatory risk.AGPU
Registration Filing16 Dec 2025 - AI oncology and ATH-focused treasury strategy drive growth amid high digital asset risk.AGPU
Registration Filing16 Dec 2025 - AI-driven oncology and ATH-focused treasury strategy create high growth and risk exposure.AGPU
Registration Filing16 Dec 2025 - Annual meeting to elect directors, ratify KPMG, and approve a new equity incentive plan.AGPU
Proxy Filing2 Dec 2025 - Proxy covers director elections, auditor, equity plan, warrant issuance, and executive pay votes.AGPU
Proxy Filing2 Dec 2025 - Shareholders will vote on director elections, auditor ratification, equity plan, and compensation.AGPU
Proxy Filing2 Dec 2025